Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

119results about How to "Control degradation" patented technology

Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes

An electrode with three-dimensional capabilities for detection and control of brain state changes of a subject. The electrode includes a disk portion having an upper surface and a lower surface, and a shaft portion secured to and extending perpendicularly outwardly from the lower surface of the disk portion; the shaft portion having an outer surface. The disk portion and shaft portion may include one or more recording or stimulating contact surfaces structured to operatively interact with the brain of a subject. Insulating material isolates each of the recording or stimulating contact surfaces from each other. At least one conductor operatively and separately connect each of the recording or stimulating contact surfaces in communication with external apparatus. The disk portion and shaft portion are structured relative to each other to operatively provide support and anchoring for each other while providing three-dimensional capabilities for detection and control of brain state changes of a subject. Modified embodiments include insertible/retractable electrode wires, both contained in channels and sheathed in axially displaceable cannulae; activating mechanisms for inserting/retracting the electrode wires and/or cannulae; and multiple shaft portions.
Owner:FLINT HILLS SCI L L C

Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes

An electrode with three-dimensional capabilities for detection and control of brain state changes of a subject. The electrode includes a disk portion having an upper surface and a lower surface, and a shaft portion secured to and extending perpendicularly outwardly from the lower surface of the disk portion; the shaft portion having an outer surface. The disk portion and shaft portion may include one or more recording or stimulating contact surfaces structured to operatively interact with the brain of a subject. Insulating material isolates each of the recording or stimulating contact surfaces from each other. At least one conductor operatively and separately connect each of the recording or stimulating contact surfaces in communication with external apparatus. The disk portion and shaft portion are structured relative to each other to operatively provide support and anchoring for each other while providing three-dimensional capabilities for detection and control of brain state changes of a subject. Modified embodiments include insertible / retractable electrode wires, both contained in channels and sheathed in axially displaceable cannulae; activating mechanisms for inserting / retracting the electrode wires and / or cannulae; and multiple shaft portions.
Owner:FLINT HILLS SCI L L C

Large-effective-area inverse dispersion compensating fiber, and a transmission line incorporating the same

An inverse dispersion fiber having a large effective area and a transmission system that incorporates the fiber for providing dispersion and dispersion slope compensation in a transmission fiber. The large-effective-area inverse dispersion optical fiber (IDF) has a negative dispersion and a negative dispersion slope. The effective area, Aeff, of the IDF preferably is greater than approximately 31 micrometers squared (μm2) at a transmission wavelength of approximately 1550 nm. The large-effective-area IDF is suitable for use with super-large-effective-area (SLA) transmission fiber for compensating dispersion in the SLA transmission fiber while reducing nonlinear effects between wavelength channels and cabling loss, which is especially advantageous in transoceanic and long-haul terrestrial systems. These nonlinear effects are inversely related to the effective area of the fiber (i.e., nonlinearities˜1/Aeff). Thus, an increase in the effective area of the fiber translates into a decrease in nonlinear interactions, which increases bandwidth capabilities and limits signal degradation. Furthermore, the large-effective-area IDF of the present invention has very desirable transmission properties. The present invention also provides a transmission system comprising at least one of the large-effective-area IDF optical fibers of the present invention. Furthermore, Aeff can be made large without having to increase the ratio, Ra, of the diameter of the core to the diameter of the trench region.
Owner:FURAKAWA ELECTRIC NORTH AMERICA INC

Preparation method for regenerated fibroin fiber

The invention relates to a preparation method for regenerated fibroin fiber, which comprises the following steps: taking regenerated fibroin water solution containing calcium ions as spinning liquid, extruding the spinning liquid out from a spinning nozzle in the temperature range of 5-35 DEG C, then curing the spinning liquid into silk in air directly, taking alcohol-water mixed solution as a finishing agent for post-processing, then taking the silk for drying, and finally obtaining the regenerated fibroin fiber. In the invention, the raw material source is wide, the cost of the raw material is low, and in the whole process, the defects that the traditional wet spinning solvent and the coagulating bath are strong in corrosion, and are toxic; in addition, compared with the other regenerated fibroin fiber dry spinning fiber, the condition of the spinning liquid is optimized, the PH regulation and other complex steps are omitted, and the use of a series of solvent is avoided. Therefore in the method, the cost is saved, and simultaneously the environment is protected. The regenerated fibroin fiber has the advantages of being non-toxic, harmless on human body and the like, is good in biocompatibility, suitable for biological and medical materials, and has good application prospect.
Owner:DONGHUA UNIV

Reactor for treating VOCs by plasma cooperating chemical catalysis

The invention discloses a reactor for treating volatile organic compounds (VOCs) by plasma cooperating chemical catalysis. The reactor comprises a shell, the shell is made of quartz glass material, one end of the shell is provided with an air inlet, and the other end of the shell is provided with an air outlet; a metallic conductive object is coated on the outer layer of the shell, and the metallic conductive object is grounded and used as a medium for blocking a discharging outer electrode; a stainless steel reaction chamber is formed in the shell, and the wall of the reaction chamber is provided with a hole, connected with an alternating current high-voltage power supply and used as a medium for blocking a discharging inner electrode; one end of the reaction chamber close to the air inlet is closed, the other end of the reaction chamber close to the air outlet is open and communicated with the air outlet, and an adsorbent and a catalyst are placed in the reaction chamber; and a certain clearance is reserved between the shell and the reaction chamber to form a medium blocked discharging air gap. The reactor integrates the functions of plasma oxidation, adsorption and catalysis, greatly increases the residence time of the VOCs in the reactor, can realize efficient degradation of the VOCs, and inhibits the generation of harmful byproducts.
Owner:ZHEJIANG GONGSHANG UNIVERSITY

Method for high content screening of therapeutic drugs for diabetes

ActiveCN101775431AStable and reliable biological cross-linking technologyControl curingMicrobiological testing/measurementPorosityHigh concentration
The invention relates to a diabetes pathological model based on cell assembly technology and application thereof in high content drug screening. Adipose-derived stem cells and simulated extracellular matrix material are assembled to form a cell-containing three-dimensional structure with certain porosity; the inducing differentiation condition is controlled to enable the adipose-derived stem cells on the surface of the inner passage of the three-dimensional structure to differentiate into endothelial cells and to enable the adipose-derived stem cells inside the matrix material to differentiate into fat cells; and pancreas islet separated out from the body of an animal is directly assembled in the gaps of the three-dimensional structure. The system model is excited for a long time by high-concentration dextrose, fatty acid insulin, TNF or cytokine secretion of fat cells and the like so as to induce the system model to produce pathology and symptom of diabetes. The drug to be tested is put into a culture system, and by detecting the level of the relevant markers of the model under normal condition and pathological condition, the pharmacological activity of the drug to be tested can be analyzed and thereby high content screening can be carried out to the drug.
Owner:HANGZHOU DIANZI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products